Are you a university-based tech project or game-changing tech companies interested in obtaining support from the EIC, Europe’s flagship innovation programme? Are you wondering how deep-tech start-ups move out of the lab and successfully make it to market? The EIC new podcast series, ‘The game changers: from radical idea to innovative business’ may help to address some of your questions.
In each episode, an EIC Programme Manager – technology experts from fascinating industries including space, energy, health and quantum – gives a deep dive into their experience scaling up European deep-tech.
Episode 6: Rapid AMR testing in the fight against TB
In this episode, we discuss a radical innovation in the field of health and biotechnology, which drastically speeds up the testing time for antibiotic resistance for tuberculosis. EMPE Diagnostics, the company behind this breakthrough, has acquired joint funding from the EIC and the Bill & Melinda Gates Foundation to develop, commercialise and scale up. On the panel are Iordanis Arzimanoglou, EIC programme manager for health and biotechnology and medical molecular geneticist, and Pavan Asalapuram, the co-founder, Vice-CEO, EMPE Diagnostics, and pharmacist and clinical biotechnologist.
You can listen to this latest release, below!
DISCLAIMER: This information is provided in the interest of knowledge sharing and should not be interpreted as the official view of the European Commission, or any other organisation.